 | • レポートコード：D0GIR-01912 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、注射型鎮痛薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。注射型鎮痛薬の種類別市場規模（非ステロイド性抗炎症薬（NSAID）、中枢鎮痛薬）、用途別市場規模（病院、クリニック、回復センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：GlaxoSmithKline、Boehringer Ingelheim、Novartis、Merck、Johson & Johson、Pfizer、Bayer、Sanofi、Sun Pharmaceutical ・地域別グローバル市場分析 2015年-2020年 ・注射型鎮痛薬の北米市場（アメリカ、カナダ、メキシコ） ・注射型鎮痛薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・注射型鎮痛薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・注射型鎮痛薬の南米市場（ブラジル、アルゼンチン） ・注射型鎮痛薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：非ステロイド性抗炎症薬（NSAID）、中枢鎮痛薬 ・用途別分析：病院、クリニック、回復センター ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Injectable Pain Medication market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Injectable Pain Medication sales will be xx in 2020 from Injectable Pain Medication million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Injectable Pain Medication market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Injectable Pain Medication industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Injectable Pain Medication and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Injectable Pain Medication market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Injectable Pain Medication market has been segmented into:
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Central Analgesics
By Application, Injectable Pain Medication has been segmented into:
Hospital
Clinics
Recovery Center
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Injectable Pain Medication market presented in the report. This section sheds light on the sales growth of different regional and country-level Injectable Pain Medication markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Injectable Pain Medication market.
The report offers in-depth assessment of the growth and other aspects of the Injectable Pain Medication market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Injectable Pain Medication Market Share Analysis
Injectable Pain Medication competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Injectable Pain Medication sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Injectable Pain Medication sales, revenue and market share for each player covered in this report.
The major players covered in Injectable Pain Medication are:
GlaxoSmithKline
Boehringer Ingelheim
Novartis
Merck
Johson & Johson
Pfizer
Bayer
Sanofi
Sun Pharmaceutical
Among other players domestic and global, Injectable Pain Medication market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Injectable Pain Medication Market Overview
1.1 Product Overview and Scope of Injectable Pain Medication
1.2 Classification of Injectable Pain Medication by Type
1.2.1 Global Injectable Pain Medication Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Injectable Pain Medication Revenue Market Share by Type in 2019
1.2.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
1.2.4 Central Analgesics
1.3 Global Injectable Pain Medication Market by Application
1.3.1 Overview: Global Injectable Pain Medication Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Recovery Center
1.4 Global Injectable Pain Medication Market by Regions
1.4.1 Global Injectable Pain Medication Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Injectable Pain Medication (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Injectable Pain Medication Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Injectable Pain Medication Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Injectable Pain Medication Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Injectable Pain Medication Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Injectable Pain Medication Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Injectable Pain Medication Industry Impact
1.5.1 COVID-19 Potential Implications for the Injectable Pain Medication
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Injectable Pain Medication
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GlaxoSmithKline SWOT Analysis
2.1.4 GlaxoSmithKline Product and Services
2.1.5 GlaxoSmithKline Injectable Pain Medication Revenue, Gross Margin and Market Share (2018-2019)
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Boehringer Ingelheim SWOT Analysis
2.2.4 Boehringer Ingelheim Product and Services
2.2.5 Boehringer Ingelheim Injectable Pain Medication Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis SWOT Analysis
2.3.4 Novartis Product and Services
2.3.5 Novartis Injectable Pain Medication Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck SWOT Analysis
2.4.4 Merck Product and Services
2.4.5 Merck Injectable Pain Medication Revenue, Gross Margin and Market Share (2018-2019)
2.5 Johson & Johson
2.5.1 Johson & Johson Details
2.5.2 Johson & Johson Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Johson & Johson SWOT Analysis
2.5.4 Johson & Johson Product and Services
2.5.5 Johson & Johson Injectable Pain Medication Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pfizer SWOT Analysis
2.6.4 Pfizer Product and Services
2.6.5 Pfizer Injectable Pain Medication Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bayer
2.7.1 Bayer Details
2.7.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Bayer SWOT Analysis
2.7.4 Bayer Product and Services
2.7.5 Bayer Injectable Pain Medication Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Sanofi SWOT Analysis
2.8.4 Sanofi Product and Services
2.8.5 Sanofi Injectable Pain Medication Revenue, Gross Margin and Market Share (2018-2019)
2.9 Sun Pharmaceutical
2.9.1 Sun Pharmaceutical Details
2.9.2 Sun Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Sun Pharmaceutical SWOT Analysis
2.9.4 Sun Pharmaceutical Product and Services
2.9.5 Sun Pharmaceutical Injectable Pain Medication Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Injectable Pain Medication Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Injectable Pain Medication Players Market Share
3.2.2 Top 10 Injectable Pain Medication Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Injectable Pain Medication Revenue and Market Share by Regions
4.2 North America Injectable Pain Medication Revenue and Growth Rate (2015-2020)
4.3 Europe Injectable Pain Medication Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Injectable Pain Medication Revenue and Growth Rate (2015-2020)
4.5 South America Injectable Pain Medication Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Injectable Pain Medication Revenue and Growth Rate (2015-2020)
5 North America Injectable Pain Medication Revenue by Countries
5.1 North America Injectable Pain Medication Revenue by Countries (2015-2020)
5.2 USA Injectable Pain Medication Revenue and Growth Rate (2015-2020)
5.3 Canada Injectable Pain Medication Revenue and Growth Rate (2015-2020)
5.4 Mexico Injectable Pain Medication Revenue and Growth Rate (2015-2020)
6 Europe Injectable Pain Medication Revenue by Countries
6.1 Europe Injectable Pain Medication Revenue by Countries (2015-2020)
6.2 Germany Injectable Pain Medication Revenue and Growth Rate (2015-2020)
6.3 UK Injectable Pain Medication Revenue and Growth Rate (2015-2020)
6.4 France Injectable Pain Medication Revenue and Growth Rate (2015-2020)
6.5 Russia Injectable Pain Medication Revenue and Growth Rate (2015-2020)
6.6 Italy Injectable Pain Medication Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Injectable Pain Medication Revenue by Countries
7.1 Asia-Pacific Injectable Pain Medication Revenue by Countries (2015-2020)
7.2 China Injectable Pain Medication Revenue and Growth Rate (2015-2020)
7.3 Japan Injectable Pain Medication Revenue and Growth Rate (2015-2020)
7.4 Korea Injectable Pain Medication Revenue and Growth Rate (2015-2020)
7.5 India Injectable Pain Medication Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Injectable Pain Medication Revenue and Growth Rate (2015-2020)
8 South America Injectable Pain Medication Revenue by Countries
8.1 South America Injectable Pain Medication Revenue by Countries (2015-2020)
8.2 Brazil Injectable Pain Medication Revenue and Growth Rate (2015-2020)
8.3 Argentina Injectable Pain Medication Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Injectable Pain Medication by Countries
9.1 Middle East & Africa Injectable Pain Medication Revenue by Countries (2015-2020)
9.2 Saudi Arabia Injectable Pain Medication Revenue and Growth Rate (2015-2020)
9.3 UAE Injectable Pain Medication Revenue and Growth Rate (2015-2020)
9.4 Egypt Injectable Pain Medication Revenue and Growth Rate (2015-2020)
9.5 South Africa Injectable Pain Medication Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Injectable Pain Medication Revenue and Market Share by Type (2015-2020)
10.2 Global Injectable Pain Medication Market Forecast by Type (2019-2024)
10.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Growth Rate (2015-2025)
10.4 Central Analgesics Revenue Growth Rate (2015-2025)
11 Global Injectable Pain Medication Market Segment by Application
11.1 Global Injectable Pain Medication Revenue Market Share by Application (2015-2020)
11.2 Injectable Pain Medication Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Recovery Center Revenue Growth (2015-2020)
12 Global Injectable Pain Medication Market Size Forecast (2021-2025)
12.1 Global Injectable Pain Medication Market Size Forecast (2021-2025)
12.2 Global Injectable Pain Medication Market Forecast by Regions (2021-2025)
12.3 North America Injectable Pain Medication Revenue Market Forecast (2021-2025)
12.4 Europe Injectable Pain Medication Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Injectable Pain Medication Revenue Market Forecast (2021-2025)
12.6 South America Injectable Pain Medication Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Injectable Pain Medication Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Injectable Pain Medication Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Injectable Pain Medication by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Injectable Pain Medication Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Injectable Pain Medication Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Injectable Pain Medication Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. GlaxoSmithKline Corporate Information, Location and Competitors
Table 7. GlaxoSmithKline Injectable Pain Medication Major Business
Table 8. GlaxoSmithKline Injectable Pain Medication Total Revenue (USD Million) (2017-2018)
Table 9. GlaxoSmithKline SWOT Analysis
Table 10. GlaxoSmithKline Injectable Pain Medication Product and Solutions
Table 11. GlaxoSmithKline Injectable Pain Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 13. Boehringer Ingelheim Injectable Pain Medication Major Business
Table 14. Boehringer Ingelheim Injectable Pain Medication Total Revenue (USD Million) (2018-2019)
Table 15. Boehringer Ingelheim SWOT Analysis
Table 16. Boehringer Ingelheim Injectable Pain Medication Product and Solutions
Table 17. Boehringer Ingelheim Injectable Pain Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Novartis Corporate Information, Location and Competitors
Table 19. Novartis Injectable Pain Medication Major Business
Table 20. Novartis Injectable Pain Medication Total Revenue (USD Million) (2017-2018)
Table 21. Novartis SWOT Analysis
Table 22. Novartis Injectable Pain Medication Product and Solutions
Table 23. Novartis Injectable Pain Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Merck Corporate Information, Location and Competitors
Table 25. Merck Injectable Pain Medication Major Business
Table 26. Merck Injectable Pain Medication Total Revenue (USD Million) (2017-2018)
Table 27. Merck SWOT Analysis
Table 28. Merck Injectable Pain Medication Product and Solutions
Table 29. Merck Injectable Pain Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Johson & Johson Corporate Information, Location and Competitors
Table 31. Johson & Johson Injectable Pain Medication Major Business
Table 32. Johson & Johson Injectable Pain Medication Total Revenue (USD Million) (2017-2018)
Table 33. Johson & Johson SWOT Analysis
Table 34. Johson & Johson Injectable Pain Medication Product and Solutions
Table 35. Johson & Johson Injectable Pain Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Pfizer Corporate Information, Location and Competitors
Table 37. Pfizer Injectable Pain Medication Major Business
Table 38. Pfizer Injectable Pain Medication Total Revenue (USD Million) (2017-2018)
Table 39. Pfizer SWOT Analysis
Table 40. Pfizer Injectable Pain Medication Product and Solutions
Table 41. Pfizer Injectable Pain Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Bayer Corporate Information, Location and Competitors
Table 43. Bayer Injectable Pain Medication Major Business
Table 44. Bayer Injectable Pain Medication Total Revenue (USD Million) (2017-2018)
Table 45. Bayer SWOT Analysis
Table 46. Bayer Injectable Pain Medication Product and Solutions
Table 47. Bayer Injectable Pain Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Sanofi Corporate Information, Location and Competitors
Table 49. Sanofi Injectable Pain Medication Major Business
Table 50. Sanofi Injectable Pain Medication Total Revenue (USD Million) (2017-2018)
Table 51. Sanofi SWOT Analysis
Table 52. Sanofi Injectable Pain Medication Product and Solutions
Table 53. Sanofi Injectable Pain Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Sun Pharmaceutical Corporate Information, Location and Competitors
Table 55. Sun Pharmaceutical Injectable Pain Medication Major Business
Table 56. Sun Pharmaceutical Injectable Pain Medication Total Revenue (USD Million) (2017-2018)
Table 57. Sun Pharmaceutical SWOT Analysis
Table 58. Sun Pharmaceutical Injectable Pain Medication Product and Solutions
Table 59. Sun Pharmaceutical Injectable Pain Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Global Injectable Pain Medication Revenue (Million USD) by Players (2015-2020)
Table 61. Global Injectable Pain Medication Revenue Share by Players (2015-2020)
Table 62. Global Injectable Pain Medication Revenue (Million USD) by Regions (2015-2020)
Table 63. Global Injectable Pain Medication Revenue Market Share by Regions (2015-2020)
Table 64. North America Injectable Pain Medication Revenue by Countries (2015-2020)
Table 65. North America Injectable Pain Medication Revenue Market Share by Countries (2015-2020)
Table 66. Europe Injectable Pain Medication Revenue (Million USD) by Countries (2015-2020)
Table 67. Asia-Pacific Injectable Pain Medication Revenue (Million USD) by Countries (2015-2020)
Table 68. South America Injectable Pain Medication Revenue by Countries (2015-2020)
Table 69. South America Injectable Pain Medication Revenue Market Share by Countries (2015-2020)
Table 70. Middle East and Africa Injectable Pain Medication Revenue (Million USD) by Countries (2015-2020)
Table 71. Middle East and Africa Injectable Pain Medication Revenue Market Share by Countries (2015-2020)
Table 72. Global Injectable Pain Medication Revenue (Million USD) by Type (2015-2020)
Table 73. Global Injectable Pain Medication Revenue Share by Type (2015-2020)
Table 74. Global Injectable Pain Medication Revenue Forecast by Type (2021-2025)
Table 75. Global Injectable Pain Medication Revenue by Application (2015-2020)
Table 76. Global Injectable Pain Medication Revenue Share by Application (2015-2020)
Table 77. Global Injectable Pain Medication Revenue Forecast by Application (2021-2025)
Table 78. Global Injectable Pain Medication Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Injectable Pain Medication Picture
Figure 2. Global Injectable Pain Medication Revenue Market Share by Type in 2019
Figure 3. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Picture
Figure 4. Central Analgesics Picture
Figure 5. Injectable Pain Medication Revenue Market Share by Application in 2019
Figure 6. Hospital Picture
Figure 7. Clinics Picture
Figure 8. Recovery Center Picture
Figure 9. Global Injectable Pain Medication Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Injectable Pain Medication Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Injectable Pain Medication Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Injectable Pain Medication Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Injectable Pain Medication Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Injectable Pain Medication Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Injectable Pain Medication Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Injectable Pain Medication Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Injectable Pain Medication Revenue Market Share in 2019
Figure 18. Global Top 10 Players Injectable Pain Medication Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Injectable Pain Medication Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Injectable Pain Medication Revenue Market Share by Regions (2015-2020)
Figure 22. Global Injectable Pain Medication Revenue Market Share by Regions in 2018
Figure 23. North America Injectable Pain Medication Revenue and Growth Rate (2015-2020)
Figure 24. Europe Injectable Pain Medication Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Injectable Pain Medication Revenue and Growth Rate (2015-2020)
Figure 26. South America Injectable Pain Medication Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Injectable Pain Medication Revenue and Growth Rate (2015-2020)
Figure 28. North America Injectable Pain Medication Revenue Market Share by Countries (2015-2020)
Figure 29. North America Injectable Pain Medication Revenue Market Share by Countries in 2019
Figure 30. USA Injectable Pain Medication Revenue and Growth Rate (2015-2020)
Figure 31. Canada Injectable Pain Medication Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Injectable Pain Medication Revenue and Growth Rate (2015-2020)
Figure 33. Europe Injectable Pain Medication Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Injectable Pain Medication Revenue Market Share by Countries in 2019
Figure 35. Germany Injectable Pain Medication Revenue and Growth Rate (2015-2020)
Figure 36. UK Injectable Pain Medication Revenue and Growth Rate (2015-2020)
Figure 37. France Injectable Pain Medication Revenue and Growth Rate (2015-2020)
Figure 38. Russia Injectable Pain Medication Revenue and Growth Rate (2015-2020)
Figure 39. Italy Injectable Pain Medication Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Injectable Pain Medication Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Injectable Pain Medication Revenue Market Share by Countries in 2019
Figure 42. China Injectable Pain Medication Revenue and Growth Rate (2015-2020)
Figure 43. Japan Injectable Pain Medication Revenue and Growth Rate (2015-2020)
Figure 44. Korea Injectable Pain Medication Revenue and Growth Rate (2015-2020)
Figure 45. India Injectable Pain Medication Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Injectable Pain Medication Revenue and Growth Rate (2015-2020)
Figure 47. South America Injectable Pain Medication Revenue Market Share by Countries (2015-2020)
Figure 48. South America Injectable Pain Medication Revenue Market Share by Countries in 2019
Figure 49. Brazil Injectable Pain Medication Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Injectable Pain Medication Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Injectable Pain Medication Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Injectable Pain Medication Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Injectable Pain Medication Revenue and Growth Rate (2015-2020)
Figure 54. UAE Injectable Pain Medication Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Injectable Pain Medication Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Injectable Pain Medication Revenue and Growth Rate (2015-2020)
Figure 57. Global Injectable Pain Medication Revenue Share by Type (2015-2020)
Figure 58. Global Injectable Pain Medication Revenue Share by Type in 2019
Figure 59. Global Injectable Pain Medication Market Share Forecast by Type (2021-2025)
Figure 60. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Growth Rate (2015-2020)
Figure 61. Global Central Analgesics Revenue Growth Rate (2015-2020)
Figure 62. Global Injectable Pain Medication Revenue Share by Application (2015-2020)
Figure 63. Global Injectable Pain Medication Revenue Share by Application in 2019
Figure 64. Global Injectable Pain Medication Market Share Forecast by Application (2021-2025)
Figure 65. Global Hospital Revenue Growth Rate (2015-2020)
Figure 66. Global Clinics Revenue Growth Rate (2015-2020)
Figure 67. Global Recovery Center Revenue Growth Rate (2015-2020)
Figure 68. Global Injectable Pain Medication Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Injectable Pain Medication Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Injectable Pain Medication Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Injectable Pain Medication Revenue Market Forecast (2021-2025)
Figure 72. Europe Injectable Pain Medication Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Injectable Pain Medication Revenue Market Forecast (2021-2025)
Figure 74. South America Injectable Pain Medication Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Injectable Pain Medication Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
市販用鎮痛剤の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Over-the-Counter Pain Medication market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Over-the-Cou…- 糖尿病用注射薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Injectable Drugs For Diabetes market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 慢性腰痛治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Chronic Low Back Pain Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Chronic Low B…
- 2型糖尿病用注射薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Injectable Drugs For Type-2 Diabete market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…
- 神経障害性鎮痛薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Neuropathic Pain Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Neuropathic Pain Drugs…